Bifidobacterium Longum

Overview

Bifidobacterium longum is a Gram-positive, obligate anaerobic bacterium and one of the most important commensal species in human health from infancy through old age. Its subspecies — B. longum subsp. longum (adult gut), B. longum subsp. infantis (infant gut, HMO degrader), and B. longum subsp. suis — occupy distinct ecological niches. In the WikiBiome framework, B. longum is significant for its heavy metal biosorption capacity, its sensitivity to prenatal metal exposure, and its role as a cross-condition protective organism.

Metal Dependencies

B. longum relies primarily on manganese and zinc rather than iron, giving it a distinct metal economy from iron-dependent pathobionts. This manganese preference contributes to its compatibility with host nutritional immunity — it does not compete for the iron that the host is actively restricting from pathogens.

Metal Detoxification Capacity

B. longum demonstrates significant capacity to bind and sequester heavy metals:

  • Cadmium biosorption — Cell wall exopolysaccharides (EPS) and peptidoglycan provide binding sites for Cd2+, reducing its bioavailability in the gut lumen and limiting intestinal absorption
  • Lead binding — Similar cell wall-mediated biosorption of Pb2+; both live and heat-killed cells retain binding capacity, though live cells additionally maintain barrier function
  • Mercury chelation — Thiol groups in surface proteins bind Hg2+

This metal-binding capacity positions B. longum alongside lactobacillus rhamnosus as a potential bioremediation organism for dietary metal exposure.

Key Enzymes and Functional Features

  • HMO glycosidases (subsp. infantis) — Sialidases, fucosidases, and N-acetylglucosaminidases that degrade human milk oligosaccharides. This HMO degradation capacity is the defining feature of the infantis subspecies and its critical role in infant gut colonization.
  • Bile salt hydrolase — Deconjugates bile acids, contributing to bile acid metabolism and fxr signaling
  • Acetate production — Primary SCFA product via the bifid shunt (fructose-6-phosphate phosphoketolase pathway); acetate cross-feeds butyrate producers

Ecological Role

In the healthy gut, B. longum provides:

  • Colonization resistance — Competitive exclusion of pathogens through acetate production and pH reduction
  • Immune programming (subsp. infantis) — Shapes neonatal immune development through HMO-derived metabolites and direct interaction with intestinal dendritic cells
  • Barrier maintenance — Supports tight junction integrity through SCFA production and direct epithelial cell signaling
  • Cross-feeding — Acetate produced by B. longum is consumed by butyrate-producing faecalibacterium prausnitzii and roseburia, linking Bifidobacterium metabolism to the butyrate economy

Conditions Associated

Lead Sensitivity

Prenatal lead exposure consistently depletes B. longum in childhood gut microbiome (ages 9-11), alongside bacteroides caccae, Bifidobacterium bifidum, and Alistipes indistinctus [1]. This represents one of the most reproducible findings in the prenatal metal-microbiome field, with B. longum exceeding the WQS importance threshold in ≥80% of repeated holdouts.

Female Fertility

B. longum abundance correlated with good ovarian stimulation response in IVF patients; gavage in mice improved outcomes — suggesting a functional role in the gut gonadal axis [2].

Cross-References

References (8)

  1. Eggers S, Midya V, Bixby M et al. (2023). Prenatal Lead Exposure is Negatively Associated with the Gut Microbiome in Childhood. Frontiers in Microbiology. doi:10.3389/fmicb.2023.1193919
  2. Fo X, Pei M, Liu P et al. (2024). Metagenomic analysis revealed the association between gut microbiota and different ovary responses to controlled ovarian stimulation. Scientific Reports. doi:10.1038/s41598-024-65869-6
  3. Huo D, Cen C, Chang H et al. (2021). Huo et al. 2021 — Probiotic Bifidobacterium longum Supplied with Methimazole Improved the Thyroid Function of Graves' Disease Patients Through the Gut-Thyroid Axis. Communications Biology. doi:10.1038/s42003-021-02587-z
  4. Shoshannah Eggers, Vishal Midya, Moira Bixby et al. (2023). Eggers 2023 — Prenatal lead exposure is negatively associated with gut microbiome in childhood (PROGRESS cohort). Frontiers in Microbiology. doi:10.3389/fmicb.2023.1193919
  5. Lorena Coretti, Lorella Paparo, Maria Pia Riccio et al. (2018). Coretti 2018 — Gut Microbiota Features in Young Children With Autism Spectrum Disorders. Frontiers in Microbiology. doi:10.3389/fmicb.2018.03146
  6. Bao K, Lin H, Guo S (2025). Gut Microbiota and Thyroid Diseases: A Comprehensive Review of Mechanisms and Clinical Implications. X-Disciplinarity
  7. Zhang Ruohan, Wang Ruting, Wu Hongxi et al. (2025). Zhang 2025 — Gut Microbiota as a Novel Target for Treating Anxiety and Depression: From Mechanisms to Multimodal Interventions. Frontiers in Microbiology. doi:10.3389/fmicb.2025.1664800
  8. Steed H, Macfarlane GT, Blackett KL et al. (2010). Clinical Trial: The Microbiological and Immunological Effects of Synbiotic Consumption - A Randomised Double-Blind Placebo-Controlled Study in Active Crohn's Disease. Alimentary Pharmacology & Therapeutics. doi:10.1111/j.1365-2036.2010.04472.x